indanidine has been researched along with 2-(n,n-dipropyl)amino-6,7-dihydroxytetralin in 1 studies
| Studies (indanidine) | Trials (indanidine) | Recent Studies (post-2010) (indanidine) | Studies (2-(n,n-dipropyl)amino-6,7-dihydroxytetralin) | Trials (2-(n,n-dipropyl)amino-6,7-dihydroxytetralin) | Recent Studies (post-2010) (2-(n,n-dipropyl)amino-6,7-dihydroxytetralin) |
|---|---|---|---|---|---|
| 26 | 0 | 1 | 11 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batink, H; de Jonge, A; Thoolen, MJ; Timmermans, PB; van Zwieten, PA; Wilffert, B | 1 |
1 other study(ies) available for indanidine and 2-(n,n-dipropyl)amino-6,7-dihydroxytetralin
| Article | Year |
|---|---|
Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood Pressure; Brain; Cell Membrane; Clonidine; Kinetics; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Vasoconstriction | 1984 |